A detailed history of Fortune Financial Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fortune Financial Advisors, LLC holds 1,039 shares of ABBV stock, worth $182,427. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,039
Holding current value
$182,427
% of portfolio
0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$163.84 - $199.33 $170,229 - $207,103
1,039 New
1,039 $205 Million
Q1 2024

Apr 23, 2024

SELL
$159.82 - $182.1 $2,237 - $2,549
-14 Reduced 0.5%
2,785 $507 Million
Q4 2023

Jan 25, 2024

SELL
$137.6 - $154.97 $51,737 - $58,268
-376 Reduced 11.84%
2,799 $434 Million
Q3 2023

Oct 25, 2023

BUY
$133.59 - $154.65 $667 - $773
5 Added 0.16%
3,175 $473 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $420,056 - $522,733
3,170 New
3,170 $427 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fortune Financial Advisors, LLC Portfolio

Follow Fortune Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortune Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortune Financial Advisors, LLC with notifications on news.